24/7 Market News Snapshot 16 September, 2024 – SciSparc Ltd. Ordinary Shares (NASDAQ:SPRC)

September 16, 2024

DENVER, Colo., 16 September, 2024 (247marketnews.com) – (NASDAQ:SPRC) are discussed in this article.
SciSparc Ltd. has recently exhibited notable trading dynamics, beginning the day at $0.315 and achieving an 18.0% increase to reach $0.354, driven by a substantial trading volume of 5.36 million shares. This surge reflects a marked investor interest which may suggest a prevailing bullish sentiment. Observers are urged to keep an eye on key resistance levels situated around $0.36 and $0.40, while support levels seem to establish themselves near $0.30. These technical indicators will be crucial for traders aiming to leverage potential price fluctuations while gauging overall market sentiment.

In a transformative development, SciSparc has also announced the filing of an international patent application in collaboration with Clearmind Medicine Inc., focusing on an innovative psychedelic combination therapy designed for mental health treatment. The patent relates to the unique combination of Ibogaine, derived from the Tabernanthe iboga shrub, paired with N-Acylethanolamines, a strategy that aims to enhance both safety and effectiveness in addressing mental health and addiction issues.

Ibogaine has displayed promise in various clinical trials targeting opioid and cocaine use disorders, while the partnership seeks to investigate the synergistic properties of psychedelic molecules alongside N-acylethanolamines such as Palmitoylethanolamide. Clearmind has actively filed thirteen related patents to support this research endeavor across numerous global jurisdictions.

In addition to its collaboration with Clearmind, SciSparc continues to advance its portfolio with a focus on therapies for Tourette Syndrome and Alzheimer’s disease, reinforcing its commitment to innovation in the pharmaceutical sphere. As the interest in psychedelic therapies escalates, both companies are strategically positioned to address the critical gaps in mental health care, potentially leading to improved outcomes for patients facing these challenging conditions.

Related news for (SPRC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.